A detailed history of Bridgeway Capital Management, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 118,110 shares of FLGT stock, worth $2.11 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
118,110
Previous 123,554 4.41%
Holding current value
$2.11 Million
Previous $2.42 Million 5.82%
% of portfolio
0.06%
Previous 0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.6 - $25.06 $106,702 - $136,426
-5,444 Reduced 4.41%
118,110 $2.57 Million
Q2 2024

Aug 14, 2024

SELL
$19.09 - $22.57 $731,547 - $864,904
-38,321 Reduced 23.67%
123,554 $2.42 Million
Q1 2024

May 15, 2024

BUY
$21.55 - $29.29 $177,248 - $240,910
8,225 Added 5.35%
161,875 $3.51 Million
Q4 2023

Feb 14, 2024

SELL
$23.64 - $30.27 $968,672 - $1.24 Million
-40,976 Reduced 21.05%
153,650 $4.44 Million
Q3 2023

Nov 14, 2023

BUY
$26.74 - $40.81 $198,571 - $303,055
7,426 Added 3.97%
194,626 $5.2 Million
Q2 2023

Aug 14, 2023

BUY
$28.52 - $40.7 $484,127 - $690,882
16,975 Added 9.97%
187,200 $6.93 Million
Q1 2023

May 15, 2023

SELL
$29.39 - $36.27 $1.15 Million - $1.42 Million
-39,075 Reduced 18.67%
170,225 $5.31 Million
Q4 2022

Feb 14, 2023

BUY
$29.23 - $40.28 $730,750 - $1.01 Million
25,000 Added 13.56%
209,300 $6.23 Million
Q3 2022

Nov 14, 2022

BUY
$37.92 - $63.74 $948,000 - $1.59 Million
25,000 Added 15.69%
184,300 $7.03 Million
Q2 2022

Aug 15, 2022

BUY
$47.98 - $62.75 $7.64 Million - $10 Million
159,300 New
159,300 $8.69 Million
Q1 2020

May 15, 2020

SELL
$6.75 - $19.75 $527,175 - $1.54 Million
-78,100 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$4.57 - $6.39 $356,917 - $499,059
78,100
78,100 $369,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $541M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.